Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter

Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September 2024 as against Rs 81.02 crore during the previous quarter ended September 2023. Sales rose 18.23% to Rs 310.18 crore in the quarter ended September 2024 as against Rs 262.35 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	310.18	262.35	18
OPM %	43.11	44.11	-
PBDT	143.65	123.00	17
PBT	130.34	109.70	19
NP	95.74	81.02	18